Who is the CEO of Chandan Healthcare Ltd?
- Answer Field
-
The chairman and managing director of Chandan Healthcare Ltd. is Dr. Amar Singh.
BAJAJ BROKING
Chandan Healthcare Limited, a well-established name in North India’s diagnostic sector, is set to launch its IPO, offering investors an opportunity to be part of its growing success. Incorporated in September 2003, the company has built a robust network of diagnostic centres, providing comprehensive pathology and radiology testing services. As of December 31, 2024, it operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, along with over 300 collection centres across 23 cities in Uttar Pradesh and 19 in Uttarakhand. This widespread presence positions Chandan Healthcare as a key player in India’s booming healthcare industry.
The company boasts an extensive test menu, offering 1,496 different tests across multiple specialities. These include 481 routine pathology tests in biochemistry and haematology, 1,015 specialised tests such as immunohistopathology and molecular pathology, and 545 radiology tests, including x-rays, ultrasonography, CT, MRI, and advanced scans. Equipped with eleven CT scanners, four MRI machines, and a team of 15 radiologists, 23 pathologists, and over 161 skilled professionals, Chandan Healthcare ensures high diagnostic accuracy. As it prepares for its IPO, investors should evaluate its market position, technological advancements, and growth potential to make an informed decision.
For more details, visit the Chandan Healthcare IPO page.
Details | Information |
IPO Date | February 10, 2025 to February 12, 2025 |
Issue Size | 67,52,000 shares (aggregating up to ₹107.36 Cr) |
Price Band | ₹151 to ₹159 per share |
Lot Size | 800 shares |
Listing At | NSE SME |
Market Maker | R.K.Stock Holding Private Limited |
Purpose of the IPO
Establishing a flagship diagnostic centre in Jankipuram, Lucknow, Uttar Pradesh.
Setting up a central reference laboratory in Ayodhya, Uttar Pradesh.
Developing a central reference laboratory in Ashiyana, Lucknow, Uttar Pradesh.
Funding general corporate needs.
Event | Date |
IPO Open Date | Monday, February 10, 2025 |
IPO Close Date | Wednesday, February 12, 2025 |
Basis of Allotment | Thursday, February 13, 2025 |
Initiation of Refunds | Friday, February 14, 2025 |
Credit of Shares to Demat | Friday, February 14, 2025 |
Listing Date | Monday, February 17, 2025 |
Cut-off time for UPI mandate confirmation | 5 PM on February 12, 2025 |
Price Band for the IPO
₹151 to ₹159 per share
Minimum Lot Size and Application Details
Application | Lots | Shares | Amount |
Retail (Min) | 1 | 800 | ₹1,27,200 |
Retail (Max) | 1 | 800 | ₹1,27,200 |
HNI (Min) | 2 | 1,600 | ₹2,54,400 |
Online Application Process
Log in to Your Trading Account
Access your trading account through your broker’s platform.
Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Select Chandan Healthcare IPO
Find "Chandan Healthcare IPO" and click on the ‘Apply’ button.
Enter Application Details
Specify the number of lots (minimum lot size: 800 shares) and the bid price within the range of ₹151 to ₹159 per share.
Provide Your UPI ID
Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.
Review and Submit
Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on February 12, 2025, to complete your application process.
Financial Health and Performance
Key Financial Metrics
Total Assets: Grew from ₹81.23 crore in FY22 to ₹170.06 crore as of December 2024.
Revenue: Reached ₹167.99 crore in FY24.
Profit After Tax (PAT): Stood at ₹17.42 crore for December 2024.
Reserves and Surplus: Recorded at ₹34.31 crore (Dec 2024), growing steadily over the years.
Total Borrowings: Increased to ₹51.92 crore (Dec 2024) from ₹16.58 crore in FY22.
Recent Performance and Growth Prospects
Significant growth in total assets over the past two years.
Consistent increase in revenue, reflecting strong business expansion.
Steady profitability with a notable rise in earnings.
Strengthened financial reserves, showing sustainable growth.
Increased borrowings to support expansion and future growth plans.
Potential Risks of Investing in the IPO
High dependency on regional markets – Chandan Healthcare operates primarily in Uttar Pradesh and Uttarakhand, which may limit its nationwide expansion and revenue diversification.
Rising operational costs – Expanding diagnostic centres and upgrading technology could increase expenses, impacting profitability in the short term.
Opportunities and Growth Potential
Expanding presence in North India – The company is setting up new diagnostic centres and laboratories, enhancing its service reach and market dominance.
Growing healthcare demand – Increasing awareness of preventive healthcare and diagnostic services in India presents a strong growth opportunity for the company.
KPI | Values |
ROE | 47.50% |
ROCE | 35.20% |
Debt/Equity | 1.02 |
RoNW | 39.54% |
PAT Margin | 9.26 |
Price to Book Value | 7.73 |
Registrar | Lead Manager(s) |
Kfin Technologies Limited | Unistone Capital Pvt Ltd |
Chandan Healthcare Limited
Biotech Park, Sector G,
Jankipuram, Kursi Road,
Lucknow-226021
Phone: +91 8429024430
Email: secretarial@chandan.co.in
Website: https://www.chandandiagnostic.com/
Chandan Healthcare Limited’s IPO marks a significant step in its expansion strategy, aiming to enhance its diagnostic network in North India. With plans to establish new flagship and central reference laboratories, the company is focused on strengthening its infrastructure and service capabilities. Its financial growth, supported by increasing revenue and asset base, reflects a steady operational trajectory.
As the IPO progresses, market participants may assess various factors, including regional concentration, operational costs, and industry trends, before making investment decisions. The healthcare diagnostics sector continues to evolve, and Chandan Healthcare’s strategic initiatives position it within a competitive landscape. For more details, visit the Chandan Healthcare IPO page.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Chandan Healthcare IPO.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer
Share this article:
The chairman and managing director of Chandan Healthcare Ltd. is Dr. Amar Singh.
The Chandan Healthcare IPO will open for subscription on February 10, 2025, and will close on February 12, 2025.
The issue size of the Chandan Healthcare SME IPO is 67,52,000 shares, aggregating up to ₹107.36 crore.
'Pre-apply' refers to the ability of investors to submit their IPO applications before the official opening date. This ensures early processing once the IPO subscription period begins.
Once you submit your IPO application and approve the UPI mandate, the confirmation is typically received within the same trading day or by the IPO closing date. Investors can check their order status through their broker’s platform or UPI app.
The lot size for the Chandan Healthcare IPO is 800 shares. The minimum order quantity is also 800 shares, amounting to ₹1,27,200 at the lower price band.
The basis of allotment will be finalized on February 13, 2025.
The registrar for the Chandan Healthcare SME IPO is Kfin Technologies Limited.
There are no reported governance issues or red flags in the provided details. Investors may refer to the company's prospectus, regulatory filings, and financial reports for further insights into its leadership and governance practices.
No Result Found
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading